ARTICLE | Finance

Takeout Food

Sofinnova: Sale of women's health play PregLem to Gedeon Richter could return 5X

October 11, 2010 7:00 AM UTC

After just over three years, Sofinnova Partners is looking at a potential return of more than 5X on portfolio company PregLem S.A., the VC's Rafaèle Tordjman told Ebb & Flow.

Last week, specialty pharma Gedeon Richter Ltd. acquired the women's health play for CHF150 million ($153.8 million) in cash and up to CHF295 million ($302.4 million) in milestones. All the milestones are needed to hit that return, but Tordjman said the milestones are achievable within a short period...